NYSE:WAT - Waters Stock Price, Forecast & News

Waters trades on the New York Stock Exchange (NYSE) under the ticker symbol "WAT."

Waters declared that its Board of Directors has initiated a share buyback program on Tuesday, April 24th 2018, which permits the company to repurchase $3,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to reacquire up to 18.2% of its stock through open market purchases. Stock repurchase programs are often a sign that the company's board believes its shares are undervalued.

Waters Co. (NYSE:WAT) issued its quarterly earnings data on Tuesday, February, 4th. The medical instruments supplier reported $3.20 EPS for the quarter, beating the consensus estimate of $3.01 by $0.19. The medical instruments supplier had revenue of $716 million for the quarter, compared to analyst estimates of $714.34 million. Waters had a net margin of 24.61% and a return on equity of 172.16%. The company's revenue for the quarter was up .1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.87 earnings per share. View Waters' Earnings History.

Waters is scheduled to release their next quarterly earnings announcement on Tuesday, April 28th 2020. View Earnings Estimates for Waters.

Waters issued an update on its FY20 earnings guidance on Tuesday, February, 4th. The company provided earnings per share (EPS) guidance of $9.15-$9.40 for the period, compared to the Thomson Reuters consensus estimate of $9.80.

11 equities research analysts have issued 1 year price objectives for Waters' shares. Their forecasts range from $177.00 to $230.00. On average, they expect Waters' share price to reach $203.71 in the next twelve months. This suggests a possible upside of 2.5% from the stock's current price. View Analyst Price Targets for Waters.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Waters in the last year. There are currently 6 sell ratings and 5 hold ratings for the stock, resulting in a consensus recommendation of "Sell." View Analyst Ratings for Waters.

News articles about WAT stock have been trending very negative on Friday, according to InfoTrie. The research group identifies positive and negative news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Waters earned a news sentiment score of -3.2 on InfoTrie's scale. They also gave news stories about the medical instruments supplier a news buzz of 4.0 out of 10, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next few days. View News Stories for Waters.

Waters saw a decline in short interest during the month of February. As of February 14th, there was short interest totalling 5,510,000 shares, a decline of 9.5% from the January 30th total of 6,090,000 shares. Based on an average daily trading volume, of 455,800 shares, the days-to-cover ratio is presently 12.1 days. Approximately 8.6% of the shares of the company are short sold. View Waters' Current Options Chain.

Some companies that are related to Waters include Thermo Fisher Scientific (TMO), Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), Charles River Laboratories Intl. (CRL), BIO-TECHNE (TECH), Bruker (BRKR), Cambrex (CBM), Luminex (LMNX), Pacific Biosciences of California (PACB), Fluidigm (FLDM), Harvard Bioscience (HBIO) and aTyr Pharma (LIFE).

Based on aggregate information from My MarketBeat watchlists, some companies that other Waters investors own include Thermo Fisher Scientific (TMO), Alibaba Group (BABA), Home Depot (HD), Honeywell International (HON), CVS Health (CVS), Procter & Gamble (PG), Raytheon (RTN), Verizon Communications (VZ), Cisco Systems (CSCO) and Northrop Grumman (NOC).

Waters' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Massachusetts Financial Services Co. MA (8.71%), Bank of New York Mellon Corp (7.14%), State Street Corp (4.50%), Baillie Gifford & Co. (3.68%), Janus Henderson Group PLC (2.55%) and Champlain Investment Partners LLC (1.55%). Company insiders that own Waters stock include Christopher A Kuebler, David Terricciano, Edward Conard, Elizabeth B Rae, Francis Kim, Ian King, Joann A Reed, Keeley A Aleman, Laurie H MD Glimcher, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Robert G Carson, Terrence P Kelly and Thomas P Salice. View Institutional Ownership Trends for Waters.

WAT stock was sold by a variety of institutional investors in the last quarter, including Fenimore Asset Management Inc., FMR LLC, State Street Corp, Baillie Gifford & Co., Jensen Investment Management Inc., Pictet Asset Management Ltd., Triodos Investment Management BV and Trillium Asset Management LLC. Company insiders that have sold Waters company stock in the last year include Edward Conard, Elizabeth B Rae, Francis Kim, Ian King, Joann A Reed, Keeley A Aleman, Laurie H MD Glimcher, Mark T Beaudouin, Robert G Carson and Terrence P Kelly. View Insider Buying and Selling for Waters.

WAT stock was acquired by a variety of institutional investors in the last quarter, including Anchor Capital Advisors LLC, Amundi Pioneer Asset Management Inc., Man Group plc, Great West Life Assurance Co. Can, Credit Suisse AG, Mawer Investment Management Ltd., Bank of New York Mellon Corp and Massachusetts Financial Services Co. MA. View Insider Buying and Selling for Waters.

Shares of WAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of WAT stock can currently be purchased for approximately $198.82.

Waters has a market capitalization of $12.81 billion and generates $2.41 billion in revenue each year. The medical instruments supplier earns $592.20 million in net income (profit) each year or $8.99 on an earnings per share basis. Waters employs 7,200 workers across the globe.View Additional Information About Waters.

The official website for Waters is http://www.waters.com/.

Waters' mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The medical instruments supplier can be reached via phone at 508-478-2000 or via email at [email protected]